Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Income towards Parent Company: 2018-2024

Historic Income towards Parent Company for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to -$177.0 million.

  • Legend Biotech's Income towards Parent Company fell 10987714385.71% to -$38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$162.6 million, marking a year-over-year decrease of 112211.55%. This contributed to the annual value of -$177.0 million for FY2024, which is 65.84% up from last year.
  • Latest data reveals that Legend Biotech reported Income towards Parent Company of -$177.0 million as of FY2024, which was up 65.84% from -$518.3 million recorded in FY2023.
  • In the past 5 years, Legend Biotech's Income towards Parent Company ranged from a high of -$177.0 million in FY2024 and a low of -$518.3 million during FY2023.
  • Its 3-year average for Income towards Parent Company is -$380.5 million, with a median of -$446.3 million in 2022.
  • As far as peak fluctuations go, Legend Biotech's Income towards Parent Company slumped by 162.20% in 2020, and later soared by 65.84% in 2024.
  • Over the past 5 years, Legend Biotech's Income towards Parent Company (Yearly) stood at -$266.4 million in 2020, then slumped by 51.51% to -$403.6 million in 2021, then dropped by 10.60% to -$446.3 million in 2022, then declined by 16.11% to -$518.3 million in 2023, then surged by 65.84% to -$177.0 million in 2024.